- Research works
- 39 ▼ 25% vs 2013–17
- Citations
- 2.6k 68.2 per fractional work
- Top-10% rate
- 15.0% record average 16.5%
- Open access
- 42% world 28%
Not ranked overall: Breast Cancer Trials is under the volume floor below which an excellence rate is noise. Not ranked is not the same as ranked last.
Field profile
Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.
Rings at 0.5×, 1× and 2×. Widest outward: Biochemistry, Genetics and Molecular Biology, 4.6×. Every wedge is a field page.
Which keywords describe research at Breast Cancer Trials?
By fractional works in all years, weighted toward what it does more of than the world: Breast Cancer, Radiotherapy, Gene Expression, Clinical Practice Guidelines, Molecular Subtypes, Survival Analysis, Prognostic Markers and Breast Tumours.
- Anxiety
- Cost-effectiveness Analysis
- Clinical Trials
- HER2
- Complications
- BRCA2
- Trastuzumab
- Precision Medicine
- Ovarian Cancer
- Chemotherapy-Induced Peripheral Neuropathy
- Nuclear Receptors
- Transcriptional Regulation
- Receptor
- Chemotherapy
- CDK4/6 Inhibitors
- Quality of Life
- Breast Tumours
- Survival Analysis
- Clinical Practice Guidelines
- Radiotherapy
- Breast Cancer
- Gene Expression
- Molecular Subtypes
- Prognostic Markers
- Treatment Response
- Metastatic Breast Cancer
- Palbociclib
- Estrogen
- Signaling
- Glucocorticoids
- Cancer Risk
- Genetic Testing
- Taxanes
- Metastatic
- BRCA1
- Cancer Survivorship
- EGFR
- Biopsy
- Health-related Quality of Life
- Health Utility Measures
Size is fractional works in all years in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.
All 40 words, with their numbers
- Breast Cancer10▲ 91×10 topics
- Radiotherapy8▲ 57×6 topics
- Gene Expression8▲ 33×6 topics
- Clinical Practice Guidelines7▲ 33×4 topics
- Molecular Subtypes7▲ 207×2 topics
- Survival Analysis7▲ 67×3 topics
- Prognostic Markers7▲ 188×2 topics
- Breast Tumours7▲ 361×1 topic
- Treatment Response7▲ 361×1 topic
- Quality of Life6▲ 12×6 topics
- Metastatic Breast Cancer5▲ 187×2 topics
- CDK4/6 Inhibitors3▲ 458×1 topic
- Palbociclib3▲ 458×1 topic
- Chemotherapy2▲ 9.2×9 topics
- Estrogen2▲ 77×2 topics
- Receptor2▲ 78×2 topics
- Signaling2▲ 50×3 topics
- Transcriptional Regulation2▲ 22×2 topics
- Glucocorticoids2▲ 97×1 topic
- Nuclear Receptors2▲ 30×1 topic
- Cancer Risk2▲ 20×4 topics
- Chemotherapy-Induced Peripheral Neuropathy2▲ 101×1 topic
- Genetic Testing2▲ 30×2 topics
- Ovarian Cancer2▲ 52×3 topics
- Taxanes2▲ 101×1 topic
- Precision Medicine2▲ 15×4 topics
- Metastatic2▲ 64×2 topics
- Trastuzumab2▲ 94×2 topics
- BRCA12▲ 150×1 topic
- BRCA22▲ 150×1 topic
- Cancer Survivorship2▲ 64×2 topics
- Complications2▲ 7.8×3 topics
- EGFR2▲ 131×1 topic
- HER22▲ 131×1 topic
- Biopsy1▲ 52×2 topics
- Clinical Trials1▲ 5.9×8 topics
- Health-related Quality of Life1▲ 16×2 topics
- Cost-effectiveness Analysis1▲ 44×1 topic
- Health Utility Measures1▲ 44×1 topic
- Anxiety1▲ 8.8×1 topic
Which research topics does Breast Cancer Trials publish most on?
By volume in 2022–2025: Breast Cancer Treatment Studies, Breast Implant and Reconstruction, Advanced Breast Cancer Therapies and Body Image and Dysmorphia Studies.
Area is fractional works; colour is the subfield each topic belongs to.
- 1 Breast Cancer Treatment Studies Cancer Research 1 works
- 2 Breast Implant and Reconstruction Surgery 0 works
- 3 Advanced Breast Cancer Therapies Pulmonary and Respiratory Medicine 0 works
- 4 Body Image and Dysmorphia Studies Clinical Psychology 0 works
- 5 BRCA gene mutations in cancer Genetics 0 works
- 6 Cancer survivorship and care Oncology 0 works
- 7 Digital Imaging in Medicine Public Health, Environmental and Occupational Health 0 works
- 8 Cancer Treatment and Pharmacology Oncology 0 works
- 9 Ethics in Clinical Research Public Health, Environmental and Occupational Health 0 works
- 10 HER2/EGFR in Cancer Research Oncology 0 works
How open and international is its research?
Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.
World: 28% of research is openly available.
World: 19% is written across borders.
How has Breast Cancer Trials's research output changed?
Output in 2018–2022 was 25% lower than in 2013–2017.
The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.
Other research institutions in Newcastle
- University of Newcastle Australia
- John Hunter Hospital
- Hunter Medical Research Institute
- Hunter New England Local Health District
- Hunter Water
- ARC Centre of Excellence for Enabling Eco-Efficient Beneficiation of Minerals
- John Hunter Children's Hospital
- CRC CARE
Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.